Cargando…

Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma

As a CRISPR-Cas9-based tool to help scientists to investigate gene functions, Cancer Dependency Map genes (CDMs) include an enormous series of loss-of-function screens based on genome-scale RNAi. These genes participate in regulating survival and growth of tumor cells, which suggests their potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Wenjie, Li, Junqing, Lu, Xiaofang, Liu, Fangjie, An, Tailai, Xiao, Xing, Kuo, Zi Chong, Wu, Wenhui, He, Yulong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959733/ https://www.ncbi.nlm.nih.gov/pubmed/33732644 http://dx.doi.org/10.3389/fonc.2021.617289

Ejemplares similares

MRPS17 promotes invasion and metastasis through PI3K/AKT signal pathway and could be potential prognostic marker for gastric cancer
por: Zhou, Wenjie, et al.
Publicado: (2021)

Prognostic Value and Biological Functions of RNA Binding Proteins in Stomach Adenocarcinoma
por: Li, Junqing, et al.
Publicado: (2021)

Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
por: Zhu, Wenhui, et al.
Publicado: (2020)

Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance
por: Wang, Kun, et al.
Publicado: (2019)

CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
por: Lu, Tongyi, et al.
Publicado: (2020)

The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
por: Wang, Luyao, et al.
Publicado: (2022)

The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening
por: Chen, Jun-Zhu, et al.
Publicado: (2023)

CRISPR/Cas9(-3NLS)/sgHMGA2@PDA nanosystem is the potential efficient gene editing therapy for gastric cancer with HMGA2 high expression
por: Wu, Zhouying, et al.
Publicado: (2022)

Application of CRISPR/Cas9 Technology to HBV
por: Lin, Guigao, et al.
Publicado: (2015)

Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
Publicado: (2021)

Development of a Novel Reference Material for Tumor Mutational Burden Measurement Based on CRISPR/Cas9 Technology
por: Peng, Rongxue, et al.
Publicado: (2022)

CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
por: Felce, Suet Ling, et al.
Publicado: (2020)

Evolution of Molecular Targeted Cancer Therapy: Mechanisms of Drug Resistance and Novel Opportunities Identified by CRISPR-Cas9 Screening
por: Hou, Jue, et al.
Publicado: (2022)

In silico Method in CRISPR/Cas System: An Expedite and Powerful Booster
por: Zhang, Yuwei, et al.
Publicado: (2020)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

Exploiting the CRISPR/Cas9 System for Targeted Genome Mutagenesis in Petunia
por: Zhang, Bin, et al.
Publicado: (2016)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment With Drug Repurposing: Proposal for Future Research
por: Martinez-Escobar, Alejandro, et al.
Publicado: (2021)

Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma
por: Luo, Wenyi, et al.
Publicado: (2022)

CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection
por: Wollebo, Hassen S., et al.
Publicado: (2015)

Integrative Analysis of CRISPR/Cas9 Target Sites in the Human HBB Gene
por: Luo, Yumei, et al.
Publicado: (2015)

Development and Validation of a Prognostic Index Based on Genes Participating in Autophagy in Patients With Lung Adenocarcinoma
por: Wu, Zi-Xuan, et al.
Publicado: (2022)

CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021)

Diagnostic, Therapeutic Predictive, and Prognostic Value of Neutrophil Extracellular Traps in Patients With Gastric Adenocarcinoma
por: Zhang, Yiyin, et al.
Publicado: (2020)

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients
por: Zhang, Yanwei, et al.
Publicado: (2020)

A Survey of Validation Strategies for CRISPR-Cas9 Editing
por: Sentmanat, Monica F., et al.
Publicado: (2018)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

CRISPR/Cas9-mediated gene targeting in Arabidopsis using sequential transformation
por: Miki, Daisuke, et al.
Publicado: (2018)

CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer
por: Almeida, Renata Sanches, et al.
Publicado: (2022)

The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy
por: Sakin, Abdullah, et al.
Publicado: (2021)

The MyLO CRISPR-Cas9 toolkit: a markerless yeast localization and overexpression CRISPR-Cas9 toolkit
por: Bean, Björn D M, et al.
Publicado: (2022)

CRISPR/Cas9-mediated targeted chromosome elimination
por: Zuo, Erwei, et al.
Publicado: (2017)

The enigmatic helicase DHX9 as a candidate prognostic biomarker for resected pancreatic ductal adenocarcinoma
por: Chen, Le-gao, et al.
Publicado: (2022)

Autophagic Heterogeneity in Gastric Adenocarcinoma
por: Yoon, Ju-Yoon, et al.
Publicado: (2021)

Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma
por: Wang, Zhenfeng, et al.
Publicado: (2023)

The predictive effect of immune therapy and chemotherapy under T cell-related gene prognostic index for Gastric cancer
por: Chen, Jingyao, et al.
Publicado: (2023)

CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines
por: Biagioni, Alessio, et al.
Publicado: (2021)

A prognostic signature model for unveiling tumor progression in lung adenocarcinoma
por: Li, Zijian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ji12ptstnkgqrgh94eb2vkgetp